(Q36439111)

14 August 2017

1 reference

title

Assessing generalisability in model-based economic evaluation studies: a structured review in osteoporosis (English)

1 reference

14 August 2017

0 references

Hege Urdahl

1

1 reference

14 August 2017

Andrea Manca

series ordinal

2

1 reference

14 August 2017

Mark J Sculpher

series ordinal

3

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

24

1 reference

14 August 2017

12

1 reference

14 August 2017

1181-1197

1 reference

Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modeling

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Generalisability in economic evaluation studies in healthcare: a review and case studies.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Using multilevel models for assessing the variability of multinational resource use and cost data.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Health economic guidelines--similarities, differences and some implications

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Perimenopausal bone density screening--will it help prevent osteoporosis?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Prevention of osteoporosis: cost-effectiveness of different pharmaceutical treatments

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Osteoporosis prevention through screening: will it be cost effective?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Estrogen use in postmenopausal women--costs, risks, and benefits

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Cost-effectiveness of hormone replacement therapy in the menopause.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

12 Cost-effectiveness of hormone replacement therapy after the menopause

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

A cost-effectiveness analysis of hormone replacement therapy in the menopause

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Estimating country-specific cost-effectiveness from multinational clinical trials

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Estimating the cost per avoided hip fracture by osteoporosis treatment in Italy.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Hormone replacement therapy in a risk-benefit perspective.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Overestimation of cost savings in prevention of osteoporosis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

HRT: an analysis of benefits, risks and costs

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Cost-effectiveness analysis for multinational clinical trials.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Analysis of costs and cost-effectiveness in multinational trials

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Cost effectiveness of nasal calcitonin in postmenopausal women: use of Cochrane Collaboration methods for meta-analysis within economic evaluation

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Are the WOSCOPS clinical and economic findings generalizable to other populations? A case study for Belgium. The WOSCOPS Economic Analysis Group. West of Scotland Coronary Prevention Study.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230686

Analyzing differences in the costs of treatment across centers within economic evaluations.

21 September 2018

1 reference

12 December 2020

A COMPARISON OF THE EFFECTIVENESS AND COST OF TREATMENT FOR VERTEBRAL FRACTURES IN WOMEN

1 reference

12 December 2020

Cost effectiveness of multi-therapy treatment strategies in the prevention of vertebral fractures in postmenopausal women with osteoporosis

1 reference

12 December 2020

Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models

1 reference

12 December 2020

Cost-effectiveness analysis of hormone replacement therapy and lifestyle intervention for hip fracture

1 reference

12 December 2020

Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy

1 reference

12 December 2020

Cost-effectiveness of hormone replacement

1 reference

12 December 2020

Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium

1 reference

12 December 2020

10.2165/00019053-200624120-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

PubMed publication ID

17129074

1 reference